NASDAQ:TVRD | Free Cash Flow | Tvardi Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$5.86M
2025-12-31-$5.69M
2025-03-31-$7.69M
2024-12-31-$4.83M$0.00-$4.83M
2024-03-31-$30.45M$836,000.00-$31.29M
2023-12-31-$17.37M$2.05M-$19.42M
2023-03-31-$34.62M
2022-12-31-$23.51M$0.00-$23.51M
2022-03-31-$25.53M$43,000.00-$25.57M
2021-12-31-$1.25M
2021-03-31-$23.72M
2020-12-31$82.09M$167,000.00$81.92M103.82%
2020-03-31-$38.3M
2019-12-31-$31.17M$0.00-$31.17M
2019-03-31-$27.53M$11,000.00-$27.54M
2018-12-31-$24.36M$24,000.00-$24.39M
2018-03-31-$18.47M$2,000.00-$18.47M
2017-12-31-$11.41M$0.00-$11.41M
2017-03-31-$21.64M$8,000.00-$21.64M
2016-12-31-$13.19M$69,000.00-$13.26M
2016-03-31-$9.83M$8,000.00-$9.84M
2015-12-31-$4.17M$7,000.00-$4.18M
2015-03-31-$5.24M$6,000.00-$5.25M
2014-12-31-$5.82M$15,000.00-$5.84M
2014-03-31-$3.09M
2013-12-31-$5.06M$1,000.00-$5.07M
2013-03-31-$1.82M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$23.5M
2024-12-31-$18.31M$1.05M-$19.35M
2023-12-31-$92.08M$2.38M-$94.45M
2022-12-31-$78.73M$43,000.00-$78.77M
2021-12-31-$60.09M$39,000.00-$60.13M
2020-12-31-$5.49M$349,000.00-$5.84M-69.39%
2019-12-31-$109.23M$18,000.00-$109.24M
2018-12-31-$22.3M$73,000.00-$22.37M
2017-12-31-$54.83M$58,000.00-$54.89M
2016-12-31-$47.38M$717,000.00-$48.1M
2015-12-31-$21.48M$20,000.00-$21.5M
2014-12-31-$17.64M$42,000.00-$17.68M
2013-12-31$2.83M$5,000.00$2.82M
2012-12-31-$6.03M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.